Literature DB >> 19917510

Multiply-primed rolling-circle amplification (MPRCA) of PCV2 genomes: applications on detection, sequencing and virus isolation.

Diogenes Dezen1, Franciscus Antonius Maria Rijsewijk, Thais Fumaco Teixeira, Carine Lidiane Holz, Samuel Paulo Cibulski, Ana Cláudia Franco, Odir Antonio Dellagostin, Paulo M Roehe.   

Abstract

Multiply-primed rolling-circle amplification (MPRCA) was used to amplify porcine circovirus type 2 (PCV2) genomes isolated from tissues of pigs with signs of post-weaning multisystemic wasting syndrome (PMWS). Two of the amplified PCV2 genomes were cloned in prokaryotic plasmids and sequenced. Both were nearly identical (1767 nt) except for one silent substitution in the region coding for the capsid protein (ORF2). In addition, they showed high nucleotide sequence similarity with PCV2 isolates from others countries (93-99%). To investigate whether the MPRCA amplified PCV2 genomes could be used to produce infectious virus, the cloned genomes were isolated from the plasmids, recircularized and used for transfection in PK-15 cells. This procedure led to the production of infectious virus to titres up to 10(5.55) TCID(50)/mL. It was concluded that MPRCA is a useful tool to amplify PCV2 genomes aiming at sequencing and virus isolation strategies, where particularly useful is the fact that it allows straightforward construction of PCV2 infectious clones from amplified genomes. However, it was less sensitive than PCR for diagnostic purposes. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917510     DOI: 10.1016/j.rvsc.2009.10.006

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  6 in total

1.  Canine papillomavirus type 16 associated to squamous cell carcinoma in a dog: virological and pathological findings.

Authors:  Christian D B T Alves; Matheus N Weber; Lorena L B Guimarães; Samuel P Cibulski; Flávio R C da Silva; Cíntia Daudt; Renata F Budaszewski; Mariana S Silva; Fabiana Q Mayer; Ronaldo M Bianchi; Claiton Ismael Schwertz; Carine R Stefanello; Daniel G Gerardi; Cláudio J M Laisse; David Driemeier; Jens P Teifke; Cláudio W Canal
Journal:  Braz J Microbiol       Date:  2020-06-04       Impact factor: 2.476

2.  Genome characterization of a bovine papillomavirus type 5 from cattle in the Amazon region, Brazil.

Authors:  Flavio R C da Silva; Cíntia Daudt; Samuel P Cibulski; Matheus N Weber; Ana Paula M Varela; Fabiana Q Mayer; Paulo M Roehe; Cláudio W Canal
Journal:  Virus Genes       Date:  2016-11-05       Impact factor: 2.332

3.  Torque teno sus virus (TTSuV) in tissues of pigs and its relation with the occurrence of postweaning multisystemic wasting syndrome.

Authors:  Thais Fumaco Teixeira; Diogenes Dezen; Samuel Paulo Cibulski; Ana Paula Muterle Varela; Camila Mengue Sheffer; Carine Lidiane Holz; Helton Fernandes Dos Santos; Ana Cláudia Franco; Paulo Michel Roehe
Journal:  Virus Genes       Date:  2013-06-20       Impact factor: 2.332

4.  Co-existence of multiple strains of porcine circovirus type 2 in the same pig from China.

Authors:  Shao-Lun Zhai; Sheng-Nan Chen; Zu-Zhang Wei; Jian-Wu Zhang; Lv Huang; Tao Lin; Cheng Yue; Duo-Liang Ran; Shi-Shan Yuan; Wen-Kang Wei; Jin-Xue Long
Journal:  Virol J       Date:  2011-11-13       Impact factor: 4.099

5.  Novel Bovine Papillomavirus Type Discovered by Rolling-Circle Amplification Coupled with Next-Generation Sequencing.

Authors:  Flavio R C da Silva; Samuel P Cibulski; Cíntia Daudt; Matheus N Weber; Lorena L B Guimarães; André F Streck; Fabiana Q Mayer; Paulo M Roehe; Cláudio W Canal
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

6.  Complete genome sequence of Deltapapillomavirus 4 (bovine papillomavirus 2) from a bovine papillomavirus lesion in Amazon Region, Brazil.

Authors:  Cíntia Daudt; Flavio R C da Silva; Samuel P Cibulski; Matheus N Weber; Fabiana Q Mayer; Ana Paula M Varela; Paulo M Roehe; Cláudio W Canal
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.